A new study in JAMA Network Open analyzed data from more than 125,000 patients who received lower-extremity revascularization between 2014 and 2019.

Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new retrospective study published in JAMA Internal Medicine.

Over the past few years, blood pressure medications have been recalled due to concerns about N-nitrosodimethylamine (NDMA), a probable carcinogen. But this may not be the only impurity to be worried about in these medications. As drug companies have addressed the NDMA issue, they have also found new potentially dangerous chemicals known as azido impurities.

Health experts now believe that daily use of low-dose aspirin—once viewed as an inexpensive and effective prophylaxis against heart disease—has more potential harms than benefits.

Results of a new pragmatic trial called ADAPTABLE will give clinicians and their patients with heart disease more to discuss when it comes to the right dose of aspirin needed to prevent another heart attack or stroke.